Blog


Blog Category:

Colon Cancer

1/4/2011
Medical Research
Comments (0)

Study emphasizes colonoscopies important

A colonoscopy is known to detect cancer on the left side of the colon but some had believed the test had a blind spot as to the right side of the colon. This study shows that the test is also effective in detecting cancer on the right side of the colon.

11/22/2010
Medical Research
Comments (0)

Missed cancers in screening colonoscopies

A new study finds that more than half of cancers arising after negative colonoscopies or after colon polyp removal were the result of missed lesions. The missed cancers can be the result of errors by the physician performing the colonoscopy, and may be medical malpractice. Contact Berger & Lagnese LLC in Pittsburgh for free consultation.

10/26/2010
Medical Research
Comments (0)

Prevent recurrence of colon and rectal cancer: one week of radiation before surgery

A new study found that recurrence of colon cancer can be prevented by giving certain patients a one week course of radiation therapy before surgical excision of the cancer tumor. The recurrence rate dropped by 50% in the study.

10/19/2010
Medical Research
Comments (0)

Low dose aspirin prevents colon cancer?

Low dose aspirin therapy over an at least 5 year period may significantly reduce the risk of colon cancer according to a Scottish research study.

9/16/2010
Medical Research
Comments (0)

Regular use of low dose aspirin may be effective in reducing risk of colon cancer by about 22%

New research from Scotland suggests that taking low-dose aspirin daily may reduce the risk of colon cancer.

9/3/2010
Medical Research
Comments (0)

Osteoporosis Drugs Linked to Colon, Esophageal and Stomach Cancers

British researchers have linked popular osteoporosis drugs with increased incidence of colon, stomach and esophageal cancer. These drugs are known as bisphosphonates and are sold under numerous labels including Fosomax, Boniva, Reclast and Actonel.

8/31/2010
Medical Research
Comments (0)

Taking Aspirin Shown to Improve Survival Rates in Non-Metastatic Colon and Rectal Cancer Patients

New studies show that people with colon or rectal cancer live longer if they take aspirin on a regular basis. Patients with non-metastatic colorectal cancer may talk to their treating doctors about whether they are appropriate candidates for regular aspirin therapy.

8/19/2010
Medical Research
Comments (0)

Chinese herbal mixture may boost chemotherapy treatment of colon cancer

Yale researchers find Chinese herbs boost effects of chemotherapy in treating colon cancer.

8/3/2010
Medical Research
Comments (0)

Pitt Researchers Testing Colon Cancer Vaccine

Researchers are working on a possible colon cancer vaccine.

7/20/2010
Medical Research
Comments (0)

Understanding the link between colon cancer and meat

Although prior studies have found a link between eating meat and increased incidence of colon cancer, this study explores the reasons why the two may be linked, and analyzes particular eating habits that are more risky.

7/10/2010
Medical Research
Comments (0)

Colon cancer in African-Americans - advances in treatment

Colon cancer is more prevalent in African-Americans, and new research shows this difference is due to genes that are susceptible to targeted drug treatment.

7/9/2010
Medical Research
Comments (0)

Colon cancer screening test less likely to detect cancer in summer compared to winter

Early detection of colon cancer is important. A common screening test for colon cancer may be less accurate in hot weather than in colder weather.

7/8/2010
Medical Research
Comments (0)

Women should increase calcium intake to reduce risk of colon cancer

New study shows evidence that women can decrease their risk of colon cancer by 45% by increasing calcium intake.

7/8/2010
Medical Research
Comments (0)

Cancer treatment: pain management and control

Cancer patients may be under-using their pain medicines for fear of side effects. Patients should discuss pain medication issues to gain understanding that using pain medicine to better control pain is beneficial and will lead to a better quality of life.

7/7/2010
Medical Research
Comments (0)

Doctors should routinely screen every adult over age 50 for colon cancer

Thirty-two thousand deaths a year could be avoided if doctors screened every adult over age 50 for colon cancer. Forty percent of eligible patients in the United States are not screened for colon cancer as they should be.

6/28/2010
Medical Research
Comments (0)

Blood test may offer early diagnosis and detection of colon cancer

Survival rate for colon cancer is linked with early diagnosis. Delayed diagnosis of colon cancer can led to unnecessary injury, and worsened prognosis including death. Blood tests for general inflammation can be linked to colon cancer and indicate heightened scrutiny for colon cancer diagnosis.

4/6/2010
Ryan Newhouse
Comments (0)

Drug Combination May Kill Precancerous Colon Polyps

A new drug combination may kill polyps that lead to colon cancer. For free information about colon cancer, contact the colon cancer attorneys of Pittsburgh, Pennsylvania.

11/19/2009
Lisa Wisilosky
Comments (0)

Study Show African-Americans With Colon Cancer Have Lower Survival Rates

If your colon cancer was missed, misdiagnosed or not properly treated, you have come to the right place. Our attorneys specialize in colon cancer cases.

7/7/2009
Lisa Wisilosky
Comments (0)

Study Shows Increase in Colorectal Cases Among Those Younger Than 50

According to a recent study that was published in Cancer Epidemiology Biomarkers and Prevention, colorectal cancer rates are on the rise in the United States for people who are younger than 50.
 
The researchers reviewed data on 11,000 men and 9,800 women younger than 50.  The data was obtained from 13 registeries that tracked the information between 1992 and 2005. 

The researchers found that colorectal cancer rates increased 1.5% a year among men younger than 50 and 1.6% a year among women younger than 50.  The researchers also found that incident rate increases for colorectal cancer had edged up in every age category below 50, but the largest increase occurred in the youngest age group (those between 20 and 29 years old). 

Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States.  The American Cancer Society estimates that about 106,000 new cases of colon cancer, which includes about 15,000 people younger than 50, and 41,000 new cases of rectal cancer will be diagnosed this year.

For free information about colon cancer, contact the medical malpractice attorneys of Pennsylvania.



4/24/2009
Lisa Wisilosky
Comments (0)

CT Colonograpy is Effective Screening for Colon Cancer

A new study, performed at the University of Wisconsin School of Medicine and Public Health, establishes CT colonography as an effective primary screening test for colon cancer.  There are several tests for diagnosing colon cancer.

 

CT colonography (CTC) allows radiologists to predict, with a high degree of confidence, whether or not a polyp needs to be evaluated through colonoscopy or removed through polypectomy.

 

The study included 479 patients with 739 CTC detected lesions.  The results of the study showed that 677 of the739 lesions or 91.6%detected on CTC were also found during optical colonoscopy or surgery.

 

This study will be presented at the 2009 American Roentgen Ray Society (ARRS) Annual Meeting in Boston, Massachusetts.

If you believe your colon cancer was missed or not diagnosed in time, you should contact the colon cancer attorneys of Pennsylvania.  We specialize in medical malpractice cases involving failure to diagnose and treat colon cancer.  Call us for a free evaluation.

 

 

 





4/3/2009
Lisa Wisilosky
Comments (0)

Erbitux May Help Some With Colorectal Cancers

People with advanced colon cancer were modestly helped by the drug Erbitux (cetuximab), as long as they didn't have a particular gene mutation, a new study reports.  Colorectal cancer is the third most common cancer worldwide.

The New England Journal of Medicine published the results of the study, which involved more than 1,100 people who had metastatic colorectal cancer that could not be surgically removed. Half were given a standard chemotherapy regimen, known as FOLFIRI, while the others were given a combination of Erbitux along with the standard regimen.

The study found that in those who had a normal form of the gene, Erbitux, which is administered intravenously, kept colorectal cancers from spreading 15% longer than did the FOLFIRI drugs alone.

Cetuximab was approved by the U.S. Food and Drug Administration in 2006 for use in squamous cell carcinoma of the head and neck. Since then, it's been increasingly used by doctors to treat colorectal cancer that has spread or recurred after other chemotherapy.

Clinical trials are ongoing to test Erbitux in people whose cancer has not yet metastasized.

For free information about colon cancer, see the colon cancer malpractice attorneys of Pennsylvania.  Colon cancer is detectable and curable, if caught early.  There are several tests for diagnosing colon cancer before it has spread.  Colon cancer typically starts with a polyp in the colon.



2/18/2009
Joshua L. Berger
Comments (0)

Medicare Will Not Pay for CT Colonoscopy (Virtual Colonoscopy) as a Screening Test for Colon Cancer

Medicare has issued a proposed decision on whether it will cover/pay for CT colonoscopy, also called virtual colonoscopy or CT colonography, for use as a screening test for colon cancer.  Medicare has proposed that it will not pay for it.  It is asking for comments on its proposed decision.  Medicare concluded that this test was not good enough at finding the smaller polyps that can lead to colon cancer.

CT colonography is performed as follows.  First, the bowel is prepared similar to the preparation used for optical colonoscopy, and stool and fluid tagged with oral contrast.  Then, a CT scan is performed in both supine and prone positions while the patient is fully conscious and produces images of the colon and rectum to assess the presence or absence of structural lesions such as polyps and colon cancer.

Originally, CT colonography produced colon images as a series of individual cross sectional images. With improved computer processing, these images can be combined into a fly-through presentation; this has led to CT colonography mimicking an optical colonoscopy.

For more information, see a summary of Medicare's proposed decision.


1/19/2009
Joshua L. Berger
Comments (0)

PET Scans Using FDG Are Very Effective at Detecting Recurrent Colon Cancer

Colon Cancer is curable. But it must be found and diagnosed early. There are several very good tests for diagnosing colon cancer, including colonoscopy and PET scans.

1/16/2009
Joshua L. Berger
Comments (0)

Vectibix Fails in Treating Metastatic Colon Cancer

At the recent Gastrointestinal Cancers Symposium Meeting, researchers reported that patients who received panitumumab (Vectibix) plus FOLFOX or FOLFIRI actually had a faster progression and spread of metastatic colon cancer and were more likely to experience severe toxicities.

Those randomized to panitumumab plus oxaliplatin and bevacizumab (Avastin) had a mean progression-free survival of 9.5 months compared with 11 months in the oxaliplatin/bevacizumab arm.

Panitumumab, a fully human monoclonal antibody that targets EGFr, is approved for monotherapy for chemotherapy-refractory metastatic colon cancer.

 There are several tests for colon cancer that enable your doctor to find and diagnose colon cancer before it spreads, including colonoscopy.



12/23/2008
David M. Paul
Comments (0)

Computer-Aided Detection Improves Colonography Polyp and Colon Cancer Detection

A new study shows that computer-aided detection (CAD) significantly increases the ability of doctors to detect colon cancer when using multi-row detector CT (MDCT) colonography (CTC) to screen for colon cancer.

If you believe your colon cancer was missed or not diagnosed in time, you should contact the lawyers at Berger & Lagnese.  Berger & Lagnese specializes in medical malpractice cases involving the failure to diagnose and treat colon cancer.  Call us for a free evaluation of your case.




Contact Us

Name:*

Phone:*

Email:*

Tell us more:*


Berger & Lagnese, LLC

310 Grant Street
Suite 720
Pittsburgh, PA 15219
Phone: (412) 471-4300
Fax: (412) 471-3116
Toll Free: (800) 350-6161
Get Directions

Testimonials

  • For a medical malpractice attorney in Pittsburgh, PA, I recommend Joshua Berger. I had a heart surgery that injured me. Attorney Berger got me a great settlement, prepared me well, and his law firm was kind and caring.
  • Attorney Paul Lagnese "He Understood"
  • The lawyers at Berger & Lagnese treated me with dignity and respect.
  • Attorney Josh Berger Recommended For Death of Man After Carotid Artery Surgery
  • Attorney David Paul reccomended for his outstanding job!
  • Attorney Paul Lagnese Recommended for Medical Malpractice Cases in Pittsburgh, Pennsylvania

View All